Literature DB >> 31668977

Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer.

Su Hyung Park1, Sejin Lee1, Jeong Ho Song1, Seohee Choi1, Minah Cho1, In Gyu Kwon1, Taeil Son1, Hyoung-Il Kim1, Jae-Ho Cheong1, Woo Jin Hyung1, Seung Ho Choi1, Sung Hoon Noh1, Yoon Young Choi2.   

Abstract

INTRODUCTION: Preoperative body weight and nutritional status are related to prognosis in patients with gastric cancer; however, the prognostic impact of postoperative in these variables is unclear. We aimed to investigate the association of preoperative/postoperative body mass index (BMI) and prognostic nutritional index (PNI) with prognosis in patients with gastric cancer.
MATERIALS AND METHODS: We retrospectively 1868 patients with stage II/III gastric cancer treated with gastrectomy between January 2006 and December 2010. We divided the populations into 3 groups according to BMI; underweight, normal, and overweight. Patients were divided into 3 groups according to BMI (underweight, normal-weight, overweight). PNI was classified into low and high (cutoff value; 49.7). The association of preoperative BMI/PNI and their changes (6 months postoperatively) with clinicopathologic characteristics were evaluated.
RESULTS: Preoperative underweight and low PNI were related to poor prognosis (log-rank p < 0.001 for both). There was a positive correlation between preoperative BMI and PNI (mean preoperative PNI: 51.13 [underweight], 53.37 [normal-weight], and 55.16 [overweight]; p < 0.001). Preoperative BMI and PNI were independent prognostic factors for disease-free survival along with age and TNM stage (p < 0.001 for both). BMI changes from normal-weight to underweight and from overweight to normal/underweight were related to poor prognosis (log-rank p = 0.021 and p = 0.013, respectively). PNI changes were related to prognosis in both the preoperative low and high PNI groups (p < 0.001 and p = 0.019, respectively).
CONCLUSION: Preoperative BMI and PNI and their postoperative changes are related to prognosis in patients with stage II/III gastric cancer. Careful nutritional intervention after gastrectomy can improve prognosis.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Body mass index; Gastric cancer; Nutrition; Prognosis; Prognostic nutritional index

Mesh:

Year:  2019        PMID: 31668977     DOI: 10.1016/j.ejso.2019.10.024

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  21 in total

1.  Preoperative Muscle-Adipose Index: A New Prognostic Factor for Gastric Cancer.

Authors:  Jun Lu; Zhen Xue; Jian-Gao Xie; Bin-Bin Xu; Hai-Bo Yang; Dong Wu; Hua-Long Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Ping Li; Chang-Ming Huang; Chao-Hui Zheng
Journal:  Ann Surg Oncol       Date:  2022-03-16       Impact factor: 5.344

2.  Clinical value and application of a novel nomogram containing inflammatory, nutritional and clinical markers in predicting overall survival of stage II/III gastric cancer patients after radical resection: a bi-centered retrospective study of 2,443 patients.

Authors:  Siyuan Liang; Chuanyi Wei; Liping Tang; Jie Gao; Wenbin Yan; Jiangchun Wu; Ziwen Long; Yanong Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

3.  Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor.

Authors:  Wei Peng; Jing Dai; Chao-Chan Liu; Dian Liu; Hua Xiao
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

4.  Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection.

Authors:  Xin Zhang; Danfang Wang; Tuanhe Sun; Wenxing Li; Chengxue Dang
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

5.  Preoperative Nutritional Status and Risk Factors Associated with Delayed Discharge in Geriatric Patients Undergoing Gastrectomy: A Single-Center Retrospective Study.

Authors:  Xining Zhao; Jie Liu; Ying Wang; Yuying Yang; Yan Pan; Shengjin Ge
Journal:  Appl Bionics Biomech       Date:  2022-06-03       Impact factor: 1.664

6.  Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy.

Authors:  Ai Tang Xiao; Yi Xin Tong; Xiang Shang Xu; Yi Zhou; Sheng Zhang
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

7.  Preoperative Controlling Nutritional Status (CONUT) score predicts short-term outcomes of patients with gastric cancer after laparoscopy-assisted radical gastrectomy.

Authors:  Yun Qian; Huaying Liu; Junhai Pan; Weihua Yu; Jiemin Lv; Jiafei Yan; Jiaqi Gao; Xianfa Wang; Xiaolong Ge; Wei Zhou
Journal:  World J Surg Oncol       Date:  2021-01-23       Impact factor: 2.754

8.  Prognostic Value of Postoperative Neutrophil and Albumin: Reassessment One Month After Gastric Cancer Surgery.

Authors:  Ali Guner; Minah Cho; Yoo-Min Kim; Jae-Ho Cheong; Woo Jin Hyung; Hyoung-Il Kim
Journal:  Front Oncol       Date:  2021-03-23       Impact factor: 6.244

9.  Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection.

Authors:  Lihu Gu; Mian Wang; Xuena Cui; Jiahang Mo; Lingling Yuan; Feiyan Mao; Kang Zhang; Derry Minyao Ng; Ping Chen; Dongjie Wang
Journal:  BMC Surg       Date:  2020-10-02       Impact factor: 2.102

10.  Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study.

Authors:  Emanuele Rinninella; Antonia Strippoli; Marco Cintoni; Pauline Raoul; Raffaella Vivolo; Mariantonietta Di Salvatore; Enza Genco; Riccardo Manfredi; Emilio Bria; Giampaolo Tortora; Antonio Gasbarrini; Carmelo Pozzo; Maria Cristina Mele
Journal:  Nutrients       Date:  2021-03-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.